drugset / Trial / NCT00964561
Ph1 Study of Valortim and Ciprofloxacin in Humans
Phase 1
Suspended
26 enrolled
PharmAthene, Inc.
Department of Health and Human Services · collabMedarex · collabNational Institutes of Health (NIH) · collabQuintiles, Inc. · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of short-term dosing of IV ciprofloxacin when administered concomitantly with IV Valortim in healthy normal human subjects.
Timeline
- Start
- 2009-08
- Primary completion
- 2010-02
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ciprofloxacin | Small molecule | 400 mg | Intravenous |
| Subject | MDX-1303 | Monoclonal antibody | 20 mg/kg | Intravenous |